Cellular immunotherapy plus chemotherapy ameliorates survival in gastric cancer patients: a meta-analysis Guoming HuKefang ZhongLiming Huang Review Article 30 July 2020 Pages: 1747 - 1756
Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study Ali GökyerAhmet Küçükardaİrfan Çiçin Original Article 26 June 2020 Pages: 1757 - 1762
Long-term cognitive outcome in adult survivors of an early childhood posterior fossa brain tumour Adam P. WagnerCliodhna CarrollHoward Ring Original Article Open access 08 July 2020 Pages: 1763 - 1773
The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan Daisuke KawakitaTakayuki MuraseHiroshi Inagaki Original Article 01 July 2020 Pages: 1774 - 1785
Why is renal impairment associated with poorer cancer specific survival in breast cancer patients?: a comparison with patients with other comorbidities Andy EvansRussell PettyJane Macaskill Original Article Open access 02 July 2020 Pages: 1786 - 1792
Phase II multi-institutional prospective trial of nab-paclitaxel as second-line chemotherapy for advanced gastric cancer refractory to fluoropyrimidine with modified dose reduction criteria (CCOG1303) Daisuke KobayashiYoshinari MochizukiYasuhiro Kodera Original Article 21 June 2020 Pages: 1793 - 1799
Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective study Shintaro NakanoSatoshi YukiYoshito Komatsu Original Article Open access 14 July 2020 Pages: 1800 - 1806
Comparison of 2- and 4-week S-1 administration as adjuvant chemotherapy for advanced gastric cancer Koichi OgawaMichitaka HondaTatsuya Oda Original Article 12 June 2020 Pages: 1807 - 1813
Protective effect of the oral administration of cystine and theanine on oxaliplatin-induced peripheral neuropathy: a pilot randomized trial Minoru KobayashiRyuichiro SatoTakashi Tsuchiya Original Article Open access 27 June 2020 Pages: 1814 - 1821
Clinicopathological characteristics and prognosis analysis of ovarian metastases in colorectal cancer: a single-center experience Rui ZhouYa LiuTao Zhang Original Article 26 June 2020 Pages: 1822 - 1829
Incidence and risk factors of parastomal hernia after ileal conduit diversion in Japanese population Kazutaka MaruoToshiaki TanakaNaoya Masumori Original Article 12 June 2020 Pages: 1830 - 1834
Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study) Naohiro OkanoChigusa MorizaneJunji Furuse Original Article 13 June 2020 Pages: 1835 - 1843
Focal therapy with high-intensity focused ultrasound for the localized prostate cancer for Asian based on the localization with MRI-TRUS fusion image-guided transperineal biopsy and 12-cores transperineal systematic biopsy: prospective analysis of oncological and functional outcomes Sunao ShojiShinichiro HiraiwaAkira Miyajima Original Article 17 June 2020 Pages: 1844 - 1853
Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or HPV infection Toshimichi OnumaTetsuji KurokawaYoshio Yoshida Original Article Open access 24 June 2020 Pages: 1854 - 1860
Intracellular accumulation of PD-1 molecules in circulating T lymphocytes in advanced malignant melanoma: an implication for immune evasion mechanism Ryo TakahashiYohei SatoManabu Ohyama Original Article 12 July 2020 Pages: 1861 - 1869
Interim analysis for post-marketing surveillance of dabrafenib and trametinib combination therapy in Japanese patients with unresectable and metastatic melanoma with BRAF V600 mutation Yasutomo TeshimaMinako KizakiMiki Harumiya Original Article Open access 22 July 2020 Pages: 1870 - 1878
Correction to: Recent advances of the regulation roles of MicroRNA in glioblastoma Chengrui YanXiangyi KongYuanli Zhao Correction 24 August 2020 Pages: 1879 - 1879